The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma

被引:0
作者
K Troppan
A Deutsch
A Gerger
T Stojakovic
C Beham-Schmid
K Wenzl
P Neumeister
M Pichler
机构
[1] Medical University of Graz (MUG),Division of Hematology, Department of Internal Medicine
[2] Medical University of Graz (MUG),Division of Oncology, Department of Internal Medicine
[3] Clinical Institute of Medical and Chemical Laboratory Diagnostics,undefined
[4] Medical University of Graz (MUG),undefined
[5] Institute of Pathology,undefined
[6] Medical University of Graz (MUG),undefined
来源
British Journal of Cancer | 2014年 / 110卷
关键词
prognosis; DLBCL; inflammatory parameter;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:369 / 374
页数:5
相关论文
共 320 条
[1]  
Absenger G(2013)A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients Br J Cancer 109 395-400
[2]  
Szkandera J(2000)Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 503-511
[3]  
Pichler M(2011)WHO classification of tumours of hematopoietic and lymphoid tissues Blood 117 5019-5032
[4]  
Stotz M(2012)Serum C- reactive protein as an important prognostic variable in patients with diffuse large B cell lymphoma Tumour Biol 33 1039-1044
[5]  
Arminger F(2002)Inflammation and cancer Nature 420 860-867
[6]  
Weissmueller M(2003)Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise Cancer Cell 4 431-436
[7]  
Schaberl-Moser R(2006)Paradoxical roles of the immune system during cancer development Nat Rev Cancer 6 24-37
[8]  
Samonigg H(2005) carcinogenesis promoted by chronic inflammation is B lymphocyte dependent Cancer Cell 7 411-423
[9]  
Stojakovic T(2012)Immuno-oncology: understanding the function and dysfunction of the immune system in cancer Annals of Oncology 23 viii6-viii9
[10]  
Gerger A(2011)New strategies in diffuse large B-cell lymphoma: translating findings from gene expression analyses into clinical practice Clin Cancer Res 17 6112-6117